Literature DB >> 12623809

Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis.

Andrea Leonardi1, Peter J Jose, Hong Zhan, Virginia L Calder.   

Abstract

OBJECTIVE: Eotaxin-1 and eotaxin-2 are potent eosinophil chemotactic and activating peptides that may be implicated in the pathogenesis of the chronic allergic eye diseases vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC). The purpose of this study was to measure these chemokines in tear and mucus samples of active-disease patients and in vitro cultured conjunctival epithelial cells and fibroblasts.
DESIGN: Comparative, observational case series and in vitro study. PARTICIPANTS: Sixteen patients with clinically active and untreated VKC or AKC, six age-matched control patients, and five nonactive seasonal allergic conjunctivitis patients.
METHODS: Tears were collected from the active VKC and AKC patients, and from the normal patients. Mucus was collected from six of these VKC patients. Tears were also collected from an additional five allergic patients after obtaining a positive reaction to conjunctival allergen challenge. Conjunctival epithelial cell and conjunctival fibroblast cultures were exposed to interleukin (IL)-4, IL-13, and tumor necrosis factor-alpha (TNF-alpha), or to combinations of these cytokines. MAIN OUTCOME MEASURES: Levels of eotaxin-1 and eotaxin-2 in tears, mucus, and culture medium.
RESULTS: High levels of eotaxin-1 and eotaxin-2 were found in mucus of VKC patients, whereas only eotaxin-2 was found to have increased significantly in tears of VKC and AKC patients compared with those of normal patients. Mucus contained higher levels of chemokines than did tears. Both tear eotaxin-1 and eotaxin-2 were correlated significantly with the percent of eosinophils in tear fluid. Eotaxin-1 also was correlated significantly with the sum clinical score and corneal involvement in VKC patients. Conjunctival epithelial cells in culture did not produce eotaxin-1 or eotaxin-2, either at baseline or after cytokine exposure. Conjunctival fibroblasts produced eotaxin-1 only after exposure to IL-4, TNF-alpha, and the combination of IL-4 plus TNF-alpha or IL-13 plus TNF-alpha.
CONCLUSIONS: Eotaxin-1 and eotaxin-2 are implicated in eosinophil recruitment and in the pathogenesis of VKC and AKC. Cytokine-stimulated conjunctival fibroblasts may be one source of eotaxin-1 in severely allergic tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623809     DOI: 10.1016/S0161-6420(02)01767-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  25 in total

1.  Relationship between tear eotaxin-2 and MMP-9 with ocular allergy and corneal topography in keratoconus patients.

Authors:  Melek Mutlu; Ozge Sarac; Nurullah Cağıl; Gamze Avcıoğlu
Journal:  Int Ophthalmol       Date:  2019-07-30       Impact factor: 2.031

2.  Fyn regulates eosinophil infiltration into the conjunctiva by downregulating the Th2 response.

Authors:  Atsuki Fukushima; Tomoko Yamaguchi; Akemi Ozaki; Taketoshi Taniguchi; Keiko Udaka; Hisayuki Ueno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

3.  Semaphorin 3A controls allergic and inflammatory responses in experimental allergic conjunctivitis.

Authors:  Junmi Tanaka; Hideo Tanaka; Nobuhisa Mizuki; Eiichi Nomura; Norihiko Ito; Naoko Nomura; Masayuki Yamane; Tomonobu Hida; Yoshio Goshima; Hiroshi Hatano; Hisashi Nakagawa
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

4.  Atopic Keratoconjunctivitis: Pharmacotherapy for the Elderly.

Authors:  Erminia Ridolo; P Kihlgren; I Pellicelli; M C Nizi; F Pucciarini; C Incorvaia
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

5.  Comparison of low-abundance biomarker levels in capillary-collected nonstimulated tears and washout tears of aqueous-deficient and normal patients.

Authors:  Nicole Guyette; Larezia Williams; My-Tho Tran; Tammy Than; John Bradley; Lucy Kehinde; Clara Edwards; Mark Beasley; Roderick Fullard
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-01       Impact factor: 4.799

6.  Th1- and Th2-type cytokines in chronic ocular allergy.

Authors:  Andrea Leonardi; Iva A Fregona; Mario Plebani; Antonio G Secchi; Virginia L Calder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117

Review 7.  Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.

Authors:  Leonard Bielory; C H Katelaris; Susan Lightman; Robert M Naclerio
Journal:  MedGenMed       Date:  2007-08-15

8.  Eotaxin-1 (CCL11) up-regulation in tears during seasonal allergic conjunctivitis.

Authors:  Simone Eperon; Alain Sauty; René Lanz; Annette Leimgruber; Floriana Lurati; Yan Guex-Crosier
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-25       Impact factor: 3.117

Review 9.  Allergy and the eye.

Authors:  A Leonardi; L Motterle; M Bortolotti
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

10.  Evaluation of eotaxin-1, -2, and -3 protein production and messenger RNA expression in patients with vernal keratoconjunctivitis.

Authors:  Jun Shoji; Noriko Inada; Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2009-03-31       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.